News & Press: Latest News

MDMA Applauds the Bipartisan, Bicameral Reintroduction of the “STRONGER Patents Act”

Wednesday, July 10, 2019  
Share |

MDMA Applauds the Bipartisan, Bicameral Reintroduction of the “STRONGER Patents Act” 

 WASHINGTON, D.C. – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today applauding the reintroduction of the “STRONGER Patents Act” in the United States Senate and House of Representatives:

MDMA applauds Senator Chris Coons, Congressman Steve Stivers and all of the co-sponsors for the bipartisan reintroduction of the ‘STRONGER Patents Act.’  In order to develop the cures and therapies of tomorrow, innovators need a predictable patent system in place.  The ‘STRONGER Patents Act’ will help restore the legal protections required to sustain our nation’s leadership in medical technology innovation.  MDMA will continue to work with Congress on this and other important policies that would help bolster America's innovation ecosystem.”

###